New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis
Franco Frati,1 Lorenzo Cecchi,2,3 Enrico Scala,4 Erminia Ridolo,5 Ilaria Dell'Albani,1 Eleni Makrì,6 Giovanni Pajno,7 Cristoforo Incorvaia6 1Medical and Scientific Department, Stallergenes, Milan, Italy; 2Interdepartmental Centre of Bioclimatology, University of Florence, Florenc...
Guardado en:
Autores principales: | Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno G, Incorvaia C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ac21c935e5bc48b2a71bbabcfaa02d42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
por: Frati F, et al.
Publicado: (2015) -
Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
por: Wang Jiarong, et al.
Publicado: (2021) -
Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
por: Galateja Jordakieva, et al.
Publicado: (2017) -
Preference for Immunotherapy with Tablets by People with Allergic Rhinitis
por: Tankersley M, et al.
Publicado: (2021) -
Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series
por: Anne K. Ellis, et al.
Publicado: (2021)